CoChat

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis

Open access
Ang, Wei Xia, Li, Zhendong, Chi, Zhixia, Du, Shou-Hui, Chen, Can, Tay, Johan C.K., Toh, Han Chong, Connolly, John E., Xu, Xue Hu, Wang, Shu · 2017 · Oncotarget
Cited by 106

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

// Wei Xia Ang 1, 2, * , Zhendong Li 1, * , Zhixia Chi 1 , Shou-Hui Du 1 , Can Chen 3 , Johan C.K. Tay 1 , Han Chong Toh 4 , John E. Connolly 5 , Xue Hu Xu 6 , Shu Wang 1, 2 1 Department of Biological Sciences, National University of Singapore 117543, Singapore 2 Institute of Bioengineering and Nanotechnology 138669, Singapore 3 Tessa Therapeutics, Pte Ltd., 239351, Singapore 4 Division of Medical Oncology, National Cancer Centre, 169610, Singapore 5 Programme in Translational Immunology, Institute for Molecular and Cell Biology 138648, Singapore 6 Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China * The authors contributed equally to these work Correspondence to: Shu Wang, email: dbsws@nus.edu.sg Keywords: peritoneal carcinomatosis, EpCAM, chimeric antigen receptor, T lymphocytes, adoptive immunotherapy Received: June 16, 2016 Accepted: January 03, 2017 Published: January 10, 2017 ABSTRACT The epithelial cell adhesion molecule (EpCAM) is overexpressed in a wide variety of tumor types, including peritoneal carcinomatosis (PC) from gastrointestinal and gynecological malignancies. To develop a chimeric antigen receptor T (CART) cell therapy approach to treat patients with end-stage PC, we constructed third generation CARs specific to EpCAM using the 4D5MOC-B single chain variable fragment. CART cells were generated with lentiviral transduction and exhibited specific in vitro killing activity against EpCAM-positive human ovarian and colorectal cancer cells. A single intraperitoneal injection of the CART cells eradicated established ovarian xenografts and resulted in significantly prolonged animal survival. Since EpCAM is also expressed on normal epithelium, anti-EpCAM CART cells were generated by mRNA electroporation that display a controlled cytolytic activity with a limited CAR expression duration. Multiple repeated infusions of these RNA CAR-modified T cells delayed disease progression in immunodeficient mice bearing well-established peritoneal ovarian and colorectal xenografts. Thus, our study demonstrates the effectiveness of using anti-EpCAM CAR-expressing T cells for local treatment of PC in mice. The possibility of using this approach for clinical treatment of EpCAM-positive gastrointestinal and gynecological malignancies warrants further validation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14592

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 106

Metadata

Authors
Ang, W. X., Li, Z., Chi, Z., Du, S.-H., Chen, C., Tay, J. C. K., Toh, H. C., Connolly, J. E., Xu, X. H., & Wang, S.
Venue
Oncotarget
Published
2017-01-10
Volume
8
Issue
8
Pages
13545-13559
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2567894773
Cited by
106
References
3
FWCI
4.95
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis. https://app.cochat.ai/papers/10.18632/oncotarget.14592
The paper
Ang, W. X., Li, Z., Chi, Z., Du, S.-H., Chen, C., Tay, J. C. K., Toh, H. C., Connolly, J. E., Xu, X. H., & Wang, S. (2017). Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis. Oncotarget. https://doi.org/10.18632/oncotarget.14592

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.